Researchers have successfully applied Nobel Prize-winning click chemistry technology for the first time in humans, enabling targeted delivery of chemotherapy drugs directly to tumors. This method reduces systemic toxicity and side effects by precisely releasing therapeutics at the tumor site. The clinical use of click chemistry represents a significant advancement in drug targeting strategies and heralds new possibilities for safer, more effective cancer therapies.